Dr Ankur Ahuja, Dr Tathagata Chatterjee, Dr Madhukar Gunjan, Dr GPS Gahlot, Dr Ajay K Baranwal, Dr Kanwaljeet Singh, Dr Beenu Singh


Context: Leishmaniasis (VL) is a chronic infection presents with fever, weight-loss, and splenomegaly. It's a mimicker of many infectious and
noninfectious illnesses.
Aims: We will highlight both the clinical and hematological spectrum of Leishmaniasis in the immunocompetent patients including their unusual
Settings and Design: During evaluation, amastigote forms of Leishmania in bone marrow were diagnosed. In all such cases serological assay of
rK39 was done which was well correlated.
Methods and Material: We performed a retrospective study of 09 months at a Tertiary Health & Research Centre of Northern India. The patients
presented with variable clinical features ranging from infectious etiology to malignant ones.
Statistical analysis used: Being a limited number of cases, no statistical software was used.
Results: Among total six patients, four presented with splenomegaly, one with renal failure and one with unilateral pleural effusion. Three and two
of such patients presented with long and short duration of fever respectively and one was afebrile. Outcome of all cases was good due to timely
diagnosis and management with intravenous liposomal amphotericin B.
Conclusion: Diagnosis of visceral leishmaniasis can be challenging due to atypical clinical presentations at times, therefore an early investigation
and prompt treatment is recommended.


Visceral Leishmaniasis (VL), Kala azar, Bone marrow aspiration (BMA), rK39 antigen, Leishmania donovani (LD) bodies, Amastigote

Full Text:



Pearson RD, De Queiroz Sousa A, Jeronimo SMB. Leishmania species: visceral (kalaazar), cutaneous and mucosal leishmaniasis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill Livingstone, 2000:2834-7.

Bhattacharya SK, Sur D, Sinha PK, Karbwang J. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable. Indian J Med Res. 2006; 123:195-6.

Garcés JM, Tomás S, Rubiés-Prat J, Gimeno JL, Drobnic L. Bacterial infection as a presenting manifestation of visceral leishmaniasis. Rev Infect Dis. 1990;12:518-9.

Rakesh Kumar, Sadhana Kumari, Jayant Prakash, Ranjit Kumar. Atypical presentations of visceral leishmaniasis: A case series and review of literature. Trop J Med Res 2015;Vol 18:02.

Andrade TM, Carvalho EM, Rocha H. Bacterial infections in patients with visceral leishmaniasis. J Infect Dis 1990;162:1354.

Seaman J, Mercer AJ, Sondorp E. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Int J Epidemiol. 1996;25:862.

Libório AB, Rocha NA, Oliveira MJ, et al. Acute kidney injury in children with visceral leishmaniasis. Pediatr Infect Dis J 2012;31:451.

Costa FA, Guerra JL, Silva SM, et al. CD4(+) T cells participate in the nephropathy of canine visceral leishmaniasis. Braz J Med Biol Res. 2000;33:1455.

Rosado FG, Kim AS. Hemophagocytic lymphohistiocytosis: an update on diagnosis and pathogenesis. Am J Clin Pathol. 2013;139:713.

Rajagopala S, Dutta U, Chandra KS, et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis case report and systematic review. J Infect. 2008;56:381.

http://journals.lww.com/pidj/Abstract/2015/12000/Hemophagocytic_Syndrome_in_Children_With_Viscer al.7.aspx (Accessed on December 08, 2015).

Nascimento ELT, Medeiros IM. Leishmaniose visceral (Calazar). Diagnostic routines and treatment of infectious and parasitic diseases.2ndedtn, Tavares W, Marine LAC (edts), Atheneu, Sao Paulo. 2007.

Ministry of Health-Health surveillance Guide. 2014 Single volume, 1st(edtn), Brasilia: Ministry of Health.

Sundar S, Rai M. Laboratory diagnosis of visceral leishmaniasis. Clin Diag Lab Immunol. 2002;9:951-8.

Qu JQ, Zhong L, MasoomYasinzai M, et al. Serodiagnosis of Asian leishmaniasis with a recombinant antigen from the repetitive domain of a Leishmania kinesin.Trans R Soc Trop Med Hyg1994;88:543.


  • There are currently no refbacks.